Ampio Pharmaceuticals, Inc.(NYSE Amex Equities : AMPE)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CTLT | Catalent, Inc. | -3.70% | 80.80 | 2.1% | $222.46m | |
| SAVA | Cassava Sciences, Inc. | -0.51% | 9.71 | 0.0% | $169.20m | |
| JAZZ | Jazz Pharmaceuticals Plc | -0.01% | 138.05 | 2.4% | $166.39m | |
| HZNP | Horizon Therapeutics Plc | -5.58% | 75.33 | 5.8% | $155.15m | |
| MRNS | Marinus Pharmaceuticals, Inc. | -10.91% | 10.70 | 7.8% | $120.06m | |
| CORT | Corcept Therapeutics, Inc. | -1.67% | 16.78 | 5.5% | $117.65m | |
| VRX | Valeant Pharmaceuticals International, Inc. | -3.24% | 15.23 | 14.1% | $89.62m | |
| BHC | Bausch Health Cos., Inc. | -3.24% | 15.23 | 0.0% | $60.32m | |
| MYOK | MyoKardia, Inc. | 0.49% | 130.02 | 1.8% | $58.56m | |
| ARGX | argenx SE | -1.13% | 243.07 | 0.0% | $54.10m | |
| AMRN | Amarin Corp. Plc | -1.09% | 3.64 | 1.5% | $53.67m | |
| SAGE | SAGE Therapeutics, Inc. | -1.83% | 58.90 | 8.6% | $45.38m | |
| GWPH | GW Pharmaceuticals Plc | -1.50% | 98.50 | 6.2% | $41.18m | |
| AXSM | Axsome Therapeutics, Inc. | -2.14% | 75.93 | 1.9% | $38.49m | |
| PRGO | Perrigo Co. Plc | -0.90% | 44.96 | 6.8% | $36.50m |
Company Profile
Ampio Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation, and sexual dysfunction and CNS disease. The company was founded by David Bar-Or in April 2010 and is headquartered in Englewood, CO.